Magali Fontaine

Publications

• A preconditioning regimen with a PKCε activator improves islet graft function in a mouse transplant model. Hamilton D, Rugg C, Davis N, Kvezereli M, Tafti BA, Busque S, Fontaine M. Cell Transplant. 2013
• A novel allocation strategy for blood transfusions: investigating the tradeoff between the age and availability of transfused blood. Atkinson MP, Fontaine MJ, Goodnough LT, Wein LM. Transfusion. 2012; 52 (1): 108-17
• Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel. Davis NE, Beenken-Rothkopf LN, Mirsoian A, Kojic N, Kaplan DL, Barron AE, Fontaine MJ. Biomaterials. 2012; 33 (28): 6691-7
• Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function. Davis NE, Hamilton D, Fontaine MJ. Curr Diab Rep. 2012; 12 (5): 612-22
• How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products. Fontaine MJ, Mills AM, Weiss S, Hong WJ, Viele M, Goodnough LT. Transfusion. 2012; 52 (10): 2081-5
• Protein polymer hydrogels: Effects of endotoxin on biocompatibility. Beenken-Rothkopf LN, Karfeld-Sulzer LS, Zhang X, Kissler H, Michie SA, Kaufman DB, Fontaine MJ, Barron AE. J Biomater Appl. 2012
• Age of blood as a limitation for transfusion: potential impact on blood inventory and availability. Fontaine MJ, Chung YT, Erhun F, Goodnough LT. Transfusion. 2011; 51 (3): 662-3
• Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients. Fontaine MJ, Kuo J, Chen G, Galel SA, Miller E, Sequeira F, Viele M, Goodnough LT, Tyan DB. Transfusion. 2011; 51 (12): 2611-8
• Disseminated intravascular coagulation due to IgM-mediated autoimmune hemolytic anemia. Bleakly NT, Fontaine MJ, Pate LL, Sutherland SM, Jeng M. Pediatr Blood Cancer. 2011; 57 (2): 329-31
• How we treat: transfusion medicine support of obstetric services. Goodnough LT, Daniels K, Wong AE, Viele M, Fontaine MF, Butwick AJ. Transfusion. 2011; 51 (12): 2540-8
• Quality management in the transfusion service: case studies in process improvement. Goodnough LT, Viele M, Fontaine M, Chua L, Ferrer Z, Jurado C, Quach P, Dunlap M, Arber DA. Transfusion. 2011; 51 (3): 600-9
• Age of blood as a limitation for transfusion: potential impact on blood inventory and availability. Fontaine MJ, Chung YT, Erhun F, Goodnough LT. Transfusion. 2010; 50 (10): 2233-9
• Immune Mediated hemolytic anemia in a pediatric patient two years after liver transplantation Fontaine MJ, CBBS Today. 2010; 28 (2): 39-41
• Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory. Fontaine MJ, Jurado C, Miller E, Viele M, Goodnough LT. Transfusion. 2010; 50 (8): 1685-9
• Standards for Cellular Therapy Product Services. Fourth Edition Padley D, Allickson J, Bollard C, Burns L, Creer M, Davis-Sproul J, Fontaine MJ, Hillberry CM, Linenberger, Linetsky E, Grable-McLeod M, Perlin T, Regan DM. American Association of Blood Banks, Bethesda, MD. 2010
• Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion. Goodnough LT, Viele M, Fontaine MJ, Jurado C, Stone N, Quach P, Chua L, Chin ML, Scott R, Tokareva I, Tabb K, Sharek PJ. Transfusion. 2009; 49 (7): 1321-8
• Improving platelet supply chains through collaborations between blood centers and transfusion services. Fontaine MJ, Chung YT, Rogers WM, Sussmann HD, Quach P, Galel SA, Goodnough LT, Erhun F. Transfusion. 2009; 49 (10): 2040-7
• Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center. Butwick AJ, Aleshi P, Fontaine M, Riley ET, Goodnough LT. Int J Obstet Anesth. 2009; 18 (4): 302-8
• Islet cell survival during isolation improved through protein kinase C epsilon activation. Kvezereli M, Vallentin A, Mochly-Rosen D, Busque S, Fontaine MJ. Transplant Proc. 2008; 40 (2): 375-8
• TSG-6 protein expression in the pancreatic islets of NOD mice. Kvezereli M, Michie SA, Yu T, Creusot RJ, Fontaine MJ. J Mol Histol. 2008; 39 (6): 585-93
• Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients. Boyd SD, Stenard F, Lee DK, Goodnough LT, Esquivel CO, Fontaine MJ. Liver Transpl. 2007; 13 (12): 1654-61
• Cold agglutinin syndrome in pediatric liver transplant recipients. Wong W, Merker JD, Nguyen C, Berquist W, Jeng M, Viele M, Glader B, Fontaine MJ. Pediatr Transplant. 2007; 11 (8): 931-6
• How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT. Transfusion. 2007; 47 (9): 1564-72
• Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH, Kim SK. Science. 2007; 318 (5851): 806-9
• Strategies to prevent TRALI reactions Fontaine MJ, CBBS Today. 2007; 25 (3): 39-42
• Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI? Fontaine MJ, Malone J, Mullins FM, Grumet FC. Ann Clin Lab Sci. 2006; 36 (1): 53-8
• Safety of red blood cell additive solutions in neonatal patients Fontaine MJ, CBBS Today. 2006; 24 (1): 29-33
• C-peptide: much more than a byproduct of insulin biosynthesis. Marques RG, Fontaine MJ, Rogers J., Pancreas. 2004; 29 (3): 231
• C-peptide: much more than a byproduct of insulin biosynthesis. Marques RG, Fontaine MJ, Rogers J. Pancreas. 2004; 29 (3): 231-8
• Use of recombinant factor VIIa in infants with severe coagulopathy. Fontaine MJ, Lazarchick J, Taylor S, Annibale D. J Perinatol. 2004; 24 (5): 310-1
• Frozen preoperative autologous blood donation for heart transplantation at the Mayo Clinic from 1988 to 1999. Fontaine MJ, Winters JL, Moore SB, McGregor CG, Santrach PJ. Transfusion. 2003; 43 (4): 476-80
• Islet cell transplantation as a cure for insulin dependent diabetes: current improvements in preserving islet cell mass and function. Fontaine MJ, Fan W. Hepatobiliary Pancreat Dis Int. 2003; 2 (2): 170-9
• Pancreatic islets activate portal vein endothelial cells in vitro. Fontaine MJ, Blanchard J, Rastellini C, Lazda V, Herold KC, Pollak R. Ann Clin Lab Sci. 2002; 32 (4): 352-61
• Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies. Fontaine M, Homburger HA, Nichols WL. Thromb Haemost. 2001; 86 (4): 1123-4
• Comparison of jejunal and ileal surveillance biopsies in a porcine model of intestinal transplantation. Raofi V, Fontaine MJ, Mihalov ML, Holman DM, Dunn TB, Vitello JM, Asolati M, Kumins NH, Benedetti E. Transplantation. 1999; 68 (2): 188-91
• Comparison of rejection rate and functional outcome of small bowel transplantation alone or in conjunction with the ileocecal valve versus combined small and large bowel transplantation. Raofi V, Holman DM, Dunn TB, Fontaine MJ, Mihalov MM, Vitello JM, Asolati M, Benedetti E. Clin Transplant. 1999; 13 (5): 389-94
• A prospective study of the predictive value of polymerase chain reaction assay for cytomegalovirus in asymptomatic kidney transplant recipients. Benedetti E, Mihalov M, Asolati M, Kirby J, Dunn T, Raofi V, Fontaine M, Pollak R. Clin Transplant. 1998; 12 (5): 391-5
• Intrasplenic hepatocyte allotransplantation in dalmation dogs with and without cyclosporine immunosuppression. Benedetti E, Kirby JP, Asolati M, Blanchard J, Ward MG, Williams R, Hewett TA, Fontaine M, Pollak R. Transplantation. 1997; 63 (9): 1206-9
• Human hepatocyte isolation and transplantation into an athymic rat, using prevascularized cell polymer constructs. Fontaine M, Schloo B, Jenkins R, Uyama S, Hansen L, Vacanti JP. J Pediatr Surg. 1995; 30 (1): 56-60
• Transplantation of genetically altered hepatocytes using cell-polymer constructs. Fontaine M, Hansen LK, Thompson S, Uyama S, Ingber DE, Langer R, Vacanti JP. Transplant Proc. 1993; 25 (1 Pt 2): 1002-4
• [Cystadenocarcinoma of the appendix]. Mary P, Razafindrajao C, Colombu JP, Fontaine M, Rouffet F. J Chir (Paris). 1990; 127 (5): 298-9
• [Surgical treatment of cancer of the left colon. True left hemicolectomy or segmental colectomy?]. Rouffet F, Fontaine M, Zerbib JJ, Mathon C. J Chir (Paris). 1988; 125 (12): 712-6